PYXS

Pyxis Oncology
$2.91
+$0.30 (+11.49%)Jul 27, 2026
2.2FairMoatMint rating

MoatMint rates Pyxis Oncology (PYXS) 2.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.5 out of 10.

Key metrics

The numbers that frame PYXS today
Market cap
$184.36M
P/E (TTM)
-2.3
EV / FCF
-2.9
Gross margin
82.8%
EV / Sales
14.1
ROIC
-96.3%
Div yield
0%
Debt / equity
0.6
52wk Low
$0.97
52wk High
$5.55

PYXS stock rating

How PYXS scores on quality, value, growth, momentum and financial health
2.2out of 10
Fair overallNeutral business, expensive priceTop 78% of ~5,000 US stocks
QualityFair3.5/10
GrowthPoor0.4/10
MomentumGood7.6/10
ValuePoor1.0/10
Financial HealthPoor1.4/10

Growth

Revenue and earnings trend for PYXS
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about PYXS
Is Pyxis Oncology a good buy?
Hold. Pyxis Oncology has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Pyxis Oncology is selling at a very high price.
What is the market capitalization of PYXS?
Pyxis Oncology's market capitalization is $184.36M.
What is the P/E ratio for PYXS stock?
Pyxis Oncology's current P/E ratio is -2.3.
What is the 52-week high for PYXS stock?
The 52-week high for Pyxis Oncology is $5.55. The current close of $2.91 is 47.6% below that high.
What is the 52-week low for PYXS stock?
The 52-week low for Pyxis Oncology is $0.97. The current close of $2.91 is 200% above that low.
Does PYXS stock pay dividends?
Pyxis Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PYXS?
Pyxis Oncology's Debt / Equity ratio is 0.58.